Loading...
•
Sep 30, 2021
Select Medical Q3 2021 Earnings Report
Announced results for the third quarter ended September 30, 2021 and the declaration of a cash dividend.
Key Takeaways
Select Medical Holdings Corporation reported a 7.8% increase in revenue to $1,534.2 million for the third quarter ended September 30, 2021, compared to $1,423.9 million for the same quarter, prior year. Net income was $100.2 million, compared to $104.5 million for the same quarter, prior year.
Revenue increased 7.8% to $1,534.2 million compared to the same quarter prior year.
Net income was $100.2 million compared to $104.5 million for the same quarter prior year.
Earnings per common share was $0.57 for both the third quarters ended September 30, 2021 and 2020.
The board of directors increased the capacity of the common stock repurchase program from $500.0 million to $1.0 billion worth of shares and the program has been extended until December 31, 2023.
Revenue by Segment
Forward Guidance
Select Medical is updating its business outlook for 2021 following the reporting of its third quarter 2021 results. Select Medical now expects revenue for the full year of 2021 to be in the range of $6.05 billion to $6.15 billion and Adjusted EBITDA for the full year of 2021 to be in the range of $980.0 million to $1.0 billion. Select Medical now expects fully diluted earnings per common share for the full year of 2021 to be in the range of $2.98 to $3.09.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...